Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin

Pseudomonas aeruginosa (PsA) is a highly prevalent bacterial organism recovered from the lungs of cystic fibrosis (CF) patients and chronic PsA infection is linked to progressive pulmonary function decline. The eradication and treatment of this organism from CF airways is particularly challenging to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Future Microbiol
Egile Nagusiak: Ehsan, Zarmina, Clancy, John P
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Future Medicine Ltd 2015
Gaiak:
Drug Evaluation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4944396/
https://ncbi.nlm.nih.gov/pubmed/26573178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fmb.15.117
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak